US Patent 10085972 Trifluoromethyl pyrazolyl guanidine F
Patent 10085972 was granted and assigned to Lycera on October, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+289 characters)
Article
Patent abstract
The invention provides trifluoromethyl pyrazolyl guanidine compounds that inhibit F1F0-ATPase, and methods of using trifluoromethyl pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alexander R. Hurd0
Clarke B. Taylor0
Jian Wang0
Peng Zhou0
Edits on 23 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 28 Jan, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10085972 Trifluoromethyl pyrazolyl guanidine F
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10085972
Date of patent
October 2, 2018
Patent application number
15631380
Date Filed
June 23, 2017
Patent primary examiner
Find more entities like US Patent 10085972 Trifluoromethyl pyrazolyl guanidine F
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.